MustGrow Biologics Corp.
MGRO.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.22% | -26.98% | -45.72% | -2,436.37% | -1,106.26% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 352.52% | 877.98% | -16.43% | -59.55% | -34.15% |
| Change in Net Operating Assets | 91.25% | 280.81% | 642.35% | 191.08% | 30.39% |
| Cash from Operations | 47.60% | 38.07% | -35.98% | -1,190.90% | -2,525.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Investing | -14,142.67% | -14,142.67% | -- | -- | -- |
| Total Debt Issued | -27.35% | -27.35% | -- | -- | -- |
| Total Debt Repaid | -- | 54.99% | 54.99% | 56.78% | 100.00% |
| Issuance of Common Stock | 3,853.35% | -- | -- | -- | 37.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -492.98% | -514.29% | -- | -- | -- |
| Cash from Financing | 159.83% | 63.54% | 1,900.85% | 1,902.61% | 1,902.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 187.76% | 59.13% | 47.78% | 59.54% | -701.89% |